Qantas (ASX:QAN) sells international flights for July

The airline throws open the gates, but here's what you need to do before going on that long-awaited overseas trip.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Qantas Airways Limited (ASX: QAN) has started selling international flights for July and beyond.

The airline had previously ruled out resumption of flights to COVID-19 hotspots like the United States and United Kingdom until at least October. It had also planned a gradual restart of international services with Singapore, Hong Kong and Tokyo resuming from the end of March.

But now all that seems to have been thrown out the window, with almost the entire international catalogue available to book from July onwards.

The Motley Fool has confirmed this on the Qantas website, able to see a $1,669 return fare to Los Angeles departing on 2 July.

"We continue to review and update our international schedule in response to the developing COVID-19 situation," a Qantas spokesperson told The Motley Fool.

"Recently we have aligned the selling of our international services to reflect our expectation that international travel will begin to restart from July 2021."

Qantas website showing a flight between Sydney and Los Angeles.

travel shares and IPO represented by man holding passport and wads of cash

Image source: Getty Images

A needle (or two) before that overseas trip

The airline's chief executive Alan Joyce had previously flagged that coronavirus vaccination would be compulsory for international passengers.

"Talking to my colleagues in other airlines around the globe, I think it's going to be a common theme," he said in November.

"What we're looking at is how you can have a vaccination passport, an electronic version of it, that certifies what the vaccine is. Is it acceptable to the country that you're travelling to?"

Qantas' may have become emboldened due to the prospect of a March rollout of vaccines in Australia.

Federal health minister Greg Hunt last week pulled forward his previous target of having the nation vaccinated by the end of the year.

"We expect that Australians will be fully vaccinated by the end of October – on the basis it's free, it's universal, and it's entirely voluntary," he said.

"But we want to urge as many Australians to be vaccinated, and we've seen some very heartening reports over the weekend of an expected uptake of up to 80 per cent."

Not all international routes are back though

While most international routes seem to have resumed, one popular destination is still a no-go zone.

Travel website Executive Traveller reported Qantas' service to New York City seems to be missing in the July reboot, as is Sydney to Santiago.

The publication also noted the Sydney-Hong Kong route is starting with a once daily schedule, rather than the pre-COVID frequency of twice daily.

Qantas previously estimated its domestic business by Christmas would be about 60% of pre-COVID levels. But the international arm had been at a standstill since March when the pandemic quashed demand.

Qantas shares have been down in the past month due to the resurgence of the virus in Sydney and Melbourne. At the time of writing, the Qantas share price is trading down 1.63% at $4.83.

Motley Fool contributor Tony Yoo owns shares of Qantas Airways Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a veritable party on the ASX today.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

ASX 200 charges higher again as relief rally gathers pace

The ASX 200 keeps climbing as global tensions begin to ease.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Arafura Rare Earths, Eagers Automotive, Life360, and Pro Medicus shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »